These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 3888492)

  • 1. Human insulin.
    Raptis S; Dimitriadis G
    Clin Physiol Biochem; 1985; 3(1):29-42. PubMed ID: 3888492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Purity and antigenicity of the new insulin preparations].
    Fankhauser S
    Schweiz Med Wochenschr; 1976 Sep; 106(36):1218-25. PubMed ID: 996531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro lymphocyte proliferation response to therapeutic insulin components. Evidence for genetic control by the human major histocompatibility complex.
    Mann DL; Mendell N; Kahn CR; Johnson AH; Rosenthal A
    J Clin Invest; 1983 Sep; 72(3):1130-8. PubMed ID: 6411767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of human insulin (Novo) or pork monocomponent insulin in HLA-DR-typed insulin-dependent diabetic individuals.
    Schernthaner G; Borkenstein M; Fink M; Mayr WR; Menzel J; Schober E
    Diabetes Care; 1983; 6 Suppl 1():43-8. PubMed ID: 6343038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behaviour of insulin antibodies in diabetics treated with different insulins.
    Mincu I; Cheţa D; Ionescu-Tîrgovişte C; Mirodon Z; Sîntu E
    Med Interne; 1980; 18(4):347-52. PubMed ID: 7006044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic allergy to human (recombinant DNA) insulin.
    Gossain VV; Rovner DR; Mohan K
    Ann Allergy; 1985 Aug; 55(2):116-8. PubMed ID: 3896050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In defence of animal insulins.
    Singh J
    J Indian Med Assoc; 2002 Mar; 100(3):171-2. PubMed ID: 12408277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Semisynthetic human insulin in the treatment of diabetes type I. Preliminary experience].
    Vitacolonna E; Consoli A; Capani F
    Boll Soc Ital Biol Sper; 1984 Oct; 60(10):1849-52. PubMed ID: 6394033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin antibodies in the maternal and foetal circulation of pregnant diabetic women treated with human insulin of recombinant DNA origin.
    Leiper JM; Fineberg SE; Lunan CB; MacCuish AC
    Diabetes Res; 1984 Jul; 1(2):75-81. PubMed ID: 6397289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity and specificity of human anti-insulin antibodies determined by isoelectric focusing.
    Thomas JW; Virta VJ; Nell LJ
    J Immunol; 1985 Feb; 134(2):1048-52. PubMed ID: 3880786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The place of "monocomponent" insulins in diabetes mellitus therapy].
    Teuscher A
    Schweiz Med Wochenschr; 1975 Apr; 105(16):485-94. PubMed ID: 1215860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of efficacy and safety of human insulin (Novo) in the treatment of insulin-dependent diabetes mellitus: a double-blind, multicenter clinical trial.
    Karam J; Brink S; Clements R; Miller L; Raskin P
    Diabetes Care; 1983; 6 Suppl 1():56-60. PubMed ID: 6343041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New insulins].
    Assan R; Marre M; Poussier P; Reach G; Eberentz C
    Journ Annu Diabetol Hotel Dieu; 1982; ():105-14. PubMed ID: 7047837
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative trials with monocomponent (MC) and monospecies (MS) pork insulins in the treatment of diabetes mellitus. Influence on antibody levels, on insulin requirement and on some complications.
    Andreani D; Iavicoli M; Tamburrano G; Menzinger G; Maltarello C
    Horm Metab Res; 1974 Nov; 6(6):447-54. PubMed ID: 4476720
    [No Abstract]   [Full Text] [Related]  

  • 15. Relative potencies of human and pork insulin during i.v. and oral glucose tolerance test in lean and obese persons.
    Nesher R; Sinai J; Litvin Y; Cerasi E
    Isr J Med Sci; 1985 Nov; 21(11):905-11. PubMed ID: 3908398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New insulins in diabetes therapy].
    Morell B
    Schweiz Med Wochenschr; 1979 Mar; 109(10):362-5. PubMed ID: 570723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biosynthetic human insulin: pharmacokinetics and effects in healthy human volunteers.
    Brogard JM; Blickle JF; Pinget M; Stahl A; Dorner M
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):575-80. PubMed ID: 6360919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating insulin antibodies during therapy with highly purified neutrally buffered insulins including desphe insulins. Report of a prospective study with 40 cases.
    Kühnau J; Rüdiger H; Goetz K
    Exp Clin Endocrinol; 1984 Apr; 83(2):161-7. PubMed ID: 6373318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The new insulins. Their characteristics and clinical indications.
    Home PD; Alberti KG
    Drugs; 1982 Nov; 24(5):401-13. PubMed ID: 6756879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition of human insulin in vitro by T cells from subjects treated with animal insulins.
    Nell LJ; Virta VJ; Thomas JW
    J Clin Invest; 1985 Dec; 76(6):2070-7. PubMed ID: 2416775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.